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Background: Rac 1 GTPase mediates glycogen phosphorylase activation and controls IL-2-stimulated T cell proliferation.
Results: PKC activates PIX by serine phosphorylation and now this Rho-GEF activates Rac 1.
Conclusion: IL-2-stimulated T cellsmigration and proliferation require the involvement of the PKC/PIX/Rac 1/PYGMpathway.
Significance:This new signaling cascademay be a viable therapeutic target to block the inflammatory responsemediated by T cells.
Recently, we have reported that the active formof Rac 1GTPase
binds to the glycogen phosphorylase muscle isoform (PYGM) and
modulates its enzymatic activity leading to T cell proliferation. In
the lymphoid system, Rac 1 and in general other small GTPases of
the Rho family participate in the signaling cascades that are acti-
vated after engagement of the T cell antigen receptor. However,
little isknownabout the IL-2-dependentRac1activatormolecules.
For the first time, a signaling pathway leading to the activation of
Rac 1/PYGM in response to IL-2-stimulated T cell proliferation is
described. More specifically, PIX, a known guanine nucleotide
exchange factor for the smallGTPases of theRho family, preferen-
tiallyRac1,mediatesPYGMactivation inKit225Tcells stimulated
with IL-2. Using directed mutagenesis, phosphorylation of PIX
Rho-GEF serines 225 and 488 is required for activation of the Rac
1/PYGM pathway. IL-2-stimulated serine phosphorylation was
corroborated inKit225Tcellscultures.Aparallelpharmacological
and genetic approach identified PKC as the serine/threonine
kinase responsible for PIX serine phosphorylation. The
phosphorylated state of PIX was required to activate first
Rac 1 and subsequently PYGM. These results demonstrate
that the IL-2 receptor activation, among other early events,
leads to activation of PKC. To activate Rac 1 and conse-
quently PYGM, PKC phosphorylates PIX in T cells. The
biological significance of this PKC/PIX/Rac 1 GTPase/
PYGM signaling pathway seems to be the control of different
cellular responses such as migration and proliferation.
Co-stimulation of T cell receptor and CD28 T cell receptors
lead to IL-2 expression and secretion. An autocrine effect is nec-
essary for expressing the IL-2 receptor (IL-2R)  chain (1, 2) and
ultimately to culminate in T cell clonal expansion (3, 4). The IL-2
effect on T cells is not only restricted to the induction of lympho-
cyte proliferation only but, in the inflammatory response it is also
necessary for T lymphocytes differentiation into effector T lym-
phocytes as well as regulatory T lymphocytes (5).
Binding of IL-2 to its high affinity receptor (IL-2R) drives the
activation of a signaling network giving rise to many cellular
responses, among them the three major signaling cascades best
characterized are the Janus kinase (Jak)/STAT and MAPK path-
ways, which modulate gene expression and PI3K-mediated cell
survival (4). To accomplish these cellular responses, IL-2-depen-
dent T cells possibly require not only activation of these pathways
but also a complex cooperation with other signaling networks
mediated by tyrosine kinases such as lck, BTK (6), PLC (7, 8), and
serine/threonine kinases such as protein kinaseC familymembers
(9, 10), and some GTPases of the Rho family. In fact, it has been
reported that RhoA cooperates with ERK-dependent signaling
pathways to transcribe c-fos in response to IL-2 (11). Moreover,
Rac 1 has also been found to participate in IL-2-induced actin
cytoskeleton rearrangement in a murine T cell line (12). More
recently, our group reported that Rac 1 binds and activates the
glycogen phosphorylasemuscle isoform (PYGM)3 and thus estab-
lished a novelmetabolic pathway that participates actively in IL-2-
stimulated cell proliferation in human T cells (13).
Signals emanating from a large variety of membrane recep-
tors: growth factor receptors (14, 15), G protein-coupled recep-
tors (16, 17), and tyrosine kinases-linked receptors such as TCR1 Supported by Dept. of Education, Basque Government Grant BFI-2010-184.2 Supported by Dept. of Industry of the Basque Government Grants
S-PE11UN018 and S-PE13UN028 and University of the Basque Country
Grants EHU11/08 and UFI 11/20. To whom correspondence should be
addressed: Dept. of Genetics, Physical Anthropology and Animal Physiol-
ogy, University of the Basque Country, Barrio de Sarriena s/n 48940 Leioa,
Spain. Tel.: 34-94-601-22-56; Fax: 34-94-601-22-56; E-mail: joseluis.
zugaza@ehu.es.
3 The abbreviations used are: PYGM, glycogen phosphorylase muscle iso-
form; RBD, Rho/Rac-binding domain; GEF, guanine nucleotide exchange
factor; BCR, B cell receptor; PMA, phorbol 12-myristate 13-acetate; EGFP,
enhanced green fluorescent protein.
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(5, 18), BCR (19, 20), and IL2-R (13), actively regulate Rho
GTPase effects. Like other small GTPases, Rho GTPases func-
tion as molecular switches that cycle between the inactive
GDP-bound and the active GTP-bound state. In the active
state, GTPases interact with downstream effector molecules to
promote a variety of biological responses, such as control of the
appropriate actin cytoskeleton reorganization in response to
extracellular signals, and their significant implications in addi-
tional biological processes, where gene expression regulation,
cell polarity, and cell migration have also been reported
(21–23).
The transition between the inactive to the active state is reg-
ulated by guanine nucleotide exchange factors (GEFs) (21–23).
A key factor in the functioning of small GTPases lies in their
selection and regulation of theseGEFs. It is well established that
upon IL-2/IL-2R ligation, Ras GEF, Son of Seven (Sos), associ-
ates toGrb2 and it is recruited through the adapter protein Shc,
to the tyrosine-phosphorylated IL-2R  chain. In this configu-
ration, Sos activates Ras and consequently the MAPK pathway
(24, 25). Therefore, Sos exchange activity is indirectly regulated
by tyrosine phosphorylation. However, the exchange activity of
some GEFs of the Dbl family that activates Rac 1 GTPase are
directly regulated by phosphorylation. In fact, in the immune
system, Vav (Rac 1-specific GEF) must be tyrosine phosphory-
lated at residue 174 to turn on its GTPase activity (26, 27). Nev-
ertheless, Tiam-1 and STEF, both members of the Tiam GEF
family where the former is mainly expressed in the brain and in
the immune system and the latter in the brain, are two addi-
tional GEFs with higher specificity for Rac 1 (28, 29) that are
activated by threonine (30) and serine/threonine phosphoryla-
tion (31), respectively. Like Tiam-1, PIX (also known as ARH-
GEF6 or Cool-2) (32–34), a Rho-GEF primarily expressed in
neurons and hematopoietic cells (34), had its exchange activity
predicted to be regulated by serine/threonine kinases phosphor-
ylation by phosphoproteomic analysis (35–38). In the last few
years, GTPases of the Rac subfamily gained increasing rele-
vance inT cell biology (39, 40). In contrast to itswell established
Sos-mediated Ras activation mechanism in IL-2-stimulated T
cells, the identity of the Rac GEF responsible for Rac activation
in IL-2-stimulated signaling has not been determined.
Here we show that subsequent to IL-2 stimulation PIX-
Rho-GEFmediates PYGMactivation in Kit 225 T cells; an IL-2-
dependent human T cell line. Serines 225 and 488 of PIX are
critical to active Rac 1 and mediate PYGM activation in IL-2-
stimulated cells. By combining pharmacological and genetic
approaches, we identified PKC as the serine/threonine kinase
that controls the phosphorylation of these serines and conse-
quently the Rac 1/PYGM axis.
These results reveal that Rac 1/PYGM pathway activation
stimulated by IL-2 is achieved through PIX. Furthermore, our
results identify PKC as the intermediary between the activated
IL-2IL-2R complex and PIX. This novel intracellular signal-
ing pathway actively participates in the regulation of the IL-2-
stimulated T cell migration and proliferation.
EXPERIMENTAL PROCEDURES
Reagents—PKA inhibitor H-89 dihydrochloride, PKC inhib-
itors Gö6976 and Rottlerin, and PI 3-kinase inhibitor LY29004
hydrochloride were obtained from Sigma. Mouse monoclonal
anti-HA antibody was obtained from Covance, mouse mono-
clonal anti-phosphoserine clone PSR-45 and rabbit monoclo-
nal anti-glutathione S-transferase (GST) antibodies were from
Sigma, mouse monoclonal anti-Rac 1 clone 23A8 antibody was
obtained from Millipore, rabbit monoclonal anti-PKC was
obtained from Cell Signaling, and enhanced chemilumines-
cence (ECL) reagent was obtained from GE Healthcare. Phor-
bol 12-myristate 13-acetate (PMA) was obtained from Sigma.
MISSION esiRNA human PRKCQ (gene synonym PKC, ref-
erence EHU093601), MISSION esiRNA human ARHGEF6
(gene synonym PIX, reference EHU133681), and MISSION
esiRNA targeting EGFP (reference EHUEGFP) were from
Sigma. IL-2 cytokine was provided by the “AIDS Research and
Reference Reagent Program,” Division of AIDS (NIAD,
National Institutes of Health).
Cell Culture andDNA/esiRNATransfections—Kit 225T cells
were cultured as described by Hori et al. (41) in the presence of
16 units/ml of recombinant human IL-2. For transient transfec-
tions, cells were cultured in complete RPMI 1640 medium in
the absence of IL-2 for 24 h. Thereafter, cells were washed,
resuspended in 200 l of serum-free medium, and placed in an
electroporation cuvette (0.4 mm, Sigma) containing 10–20 g
of different plasmids, or 15 ng of esiRNAs. Electroporation was
carried out in a Gene Pulser Xcell Electroporator (Bio-Rad) at
260 V and 950 microfarads (13). The cuvette content was col-
lected into 10ml of complete RPMI 1640medium and cultured
in the absence of IL-2 for an additional 24 h.
Agonists and Inhibitors—Kit 225 T cells were maintained in
the absence of IL-2 for 48 h and subsequently stimulated with
500 units/ml of IL-2 at 37 °C (13). In some experiments, Kit 225
T cells were pretreated with 10 M H-89 (PKA inhibitor) or 20
M LY29004 (PI3K inhibitor) or 100 nM Gö6976 and different
concentrations of Rottlerin (PKC inhibitors) for 1 h prior to
IL-2 or PMA stimulation (13, 42).
Plasmid Construct and Site-directed Mutagenesis—The
PIX comprising amino acids 204–532 (PIX204–532) was gen-
erated by PCR amplification using pMT2-HA-PIX wt as tem-
plate (forward oligonucleotide, 5-CGG GAT CCA GAA CAG
GCT GG-3, and reverse oligonucleotide 5-GCG GAT CCT
GTG CAG TCA TTC C-3, each harboring BamHI restriction
sites (underlined). The BamHI PIX204–532 fragment was sub-
cloned into pGEX-4T3 (GE Healthcare) to generate the GST-
PIX204–532 fusion protein. pMT2-HA-PIXS225A, pMT2-
HA-PIXS488A, and pMT2-HA-PIXS225A/S488A single and
double mutated constructs were generated according to
manufacturer’s instructions (QuikChange Lightning Site-di-
rected Mutagenesis Kit, Stratagene). Oligonucleotides used for
S225A mutation were: 5-GAG AGA CCT CTC GCC CCA
AAA GCC GTC-3 (forward) and 5-GAC GGC TTT TGG
GGC GAG AGG TCT CTC-3 (reverse) and for S488A muta-
tion were: 5-AGT CCT CGG ATG GCT GGC TTT ATC
TAT-3 (forward) and 5-ATA GAT AAA GCC AGC CAT
CCG AGG ACT-3 (reverse).
Activity Assay for Glycogen Phosphorylase—The glycogen
phosphorylase activity assay was performed as previously
described (43, 44) with some modifications. Briefly, cells were
washed twice with cold PBS and resuspended in 500 l of TES
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buffer (20 mM Tris, pH 7.4, 1 mM EDTA, 225 mM sucrose, 2.5
mMDTT, 0.1mM PMSF, 1g/ml of leupeptin, 1g/ml of apro-
tinin). Sampleswere sonicated and centrifuged at 12,300 g for
10 min at 4 °C. Total protein (100 g) was used to measure
PYGM activity in assay buffer (50 mM KH2PO4, pH 7.5, 10 mM
MgCl2, 5 mM EDTA, pH 8, 0.5 mM NADP, 1.5 units/ml of
glucose-6-phosphate dehydrogenase, 1 unit/ml of phosphoglu-
comutase, 0.1 mg/ml of glycogen (all from Sigma). Assay buffer
containing 300 l of TES without NADP, glycogen, phospho-
glucomutase, and glucose-6-phosphate dehydrogenase was
added to 100g of total protein as a blank control. To carry out
the metabolic activity assay the mixture was incubated at 37 °C
for 20 min. By placing samples on ice the reaction was stopped.
Sample absorbances were detected at 340 nm in a spectropho-
tometer (Ultrospec 3100 pro, Amersham Biosciences). The
amount of NADPH formed was determined using a standard
curve of known NADPH concentrations (Sigma).
Rac 1 Activation Assay—Rac 1 pulldown assay was per-
formed using a GST fusion protein containing the Rac 1 bind-
ing domain of PAK1 (GST-RBD-PAK1). Transfected and
untransfected cells kept in the absence of IL-2 for 48 h were
stimulated with IL-2 for 10 min and lysed as described in Ref.
45. Cell lysates were centrifuged at 12,300 g for 10min at 4 °C
and incubated for 1 h at 4 °C with 50 g of GST-RBD-PAK1
fusion protein coupled to glutathione-Sepharose beads. Precip-
itated proteins were eluted from beads using 2 loading buffer
(12 mM Tris, pH 6.8, 5% glycerol, 0.4% SDS, 140 mM 2-mercap-
toethanol, 0.02% bromphenol blue), separated by SDS-PAGE,
and analyzed by immunoblot with specific monoclonal anti-
bodies. Immunoreactive bands were visualized using ECL.
Immunoprecipitation Assay—Transfected Kit 225 T cells
with cDNA encoding for pMT2-HA-PIX or empty vector
(pMT2-HA) or esiRNAs to knock downPKC as indicatedwere
treated or not with 500 units/ml of IL-2 for 10 min. Cells were
washed three times in ice-cold PBS and lysed in RIPA buffer (50
mM Tris, pH 7.4, 150 mM NaCl, 1% IGEPAL, 0.25% Na-deoxy-
colate, 1 mM EDTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF, 1
g/ml of aprotinin, 1 g/ml of leupeptin). Ectopic HA-PIX
and endogenous PIXwere immunoprecipitated for 2 h at 4 °C
using anti-HA or anti-PIX antibodies. Immune complexes
were recovered using Gamma Bind Plus-Sepharose beads (GE
Healthcare, Pittsburgh, PA), washed, and eluted from beads
and resolved electrophoretically by SDS-PAGE and analyzed by
Western blot with anti-phosphoserine, anti-HA, or anti-PIX
antibodies. Immunoreactive bands were visualized using ECL.
In Vitro Kinase Assay—Kit 225 T cells transfected with PKC
(wild type), PKCK409R (dominant-negative), and/or the consti-
tutively active forms of PKC (PKCA25E), PKC (PKCA159E),
and PKC (PKCA148E) were incubated in the presence or
absence of 500 units/ml of IL-2 for 10 min at 37 °C and washed
twice with cold PBS. Thereafter, cells were lysed with lysis
buffer (20 mM Tris, pH 7.4, 137 mM NaCl, 5 mM EDTA, 1 mM
EGTA, 10 mM NaF, 1 mM sodium pyrophosphate, 100 mM
-glycerophosphate, 10 g/ml of aprotinin, 1 mM PMSF, 10%
glycerol, and 1% (v/v) Triton X-100) and lysates were clarified
by centrifugation for 10 min at 12,300  g at 4 °C. PKCs were
immunoprecipitated with specific antibodies and immuno-
complexes were recovered using Gamma Bind Plus-Sepharose
beads (GE Healthcare). The immunocomplexes were washed
twice with cold lysis buffer, twice with cold washing buffer (10
mM HEPES, pH 7.4, 100 mM NaCl, 20 g/ml of aprotinin, and
0.5% IGEPAL-360) and twice with reaction buffer (20 mM Tris,
pH 7.4, 20 mM NaCl, 1 mM DTT, 10 mM MgCl2, and 1 mM
MnCl2). 500 ng of purified recombinant GST-PIX204–532,
which encompasses the two potential serine phosphorylation
sites (Ser225 and Ser488) of PIX (33), and 20 M ATP was then
added to the reaction mixture. The in vitro kinase reaction was
carried out for 30 min at 30 °C after which it was stopped by
adding 30 l of 2 loading buffer. Proteins were separated by
SDS-PAGE, followed by Western blot. Immunoreactive bands
were visualized with anti-phosphoserine antibody and ECL.
Cell Migration Assay—esiRNA-transfected cell suspensions
(2.5 105 cells in a 100-l volume) were placed into the upper
chamber, whereas 600 l of medium with or without IL-2 (500
units/ml) was introduced into the lower chamber. Both cham-
bers were incubated overnight at 37 °C in 5% CO2 and 95% air.
Cells in the upper and bottom chamber were recovered sepa-
rately into equal volumes for cell counting. The percentage of
migrating cells was determined as follows: [number of cells
migrating (lower chamber)/total number of cells (cells in the
lower chamber  remaining cells in the upper chamber)].
Assay was performed using pore filters (8m,CorningCostar
Transwell and cell culture inserts were from Sigma) and cell
counts were done in triplicate.
Cell Proliferation Measurement—esiRNA-transfected cells
were seeded in 24-well plates in complete RPMI (106 cells/ml),
and maintained in the absence of IL-2 for 48 h. Subsequently,
cells (106) were incubated with 4 M PKH26 following the
manufacturer’s instructions (Sigma). A sample (104 cells)
was taken as the start control, another sample (104 cells) was
left untreated, and the remaining cells were incubated in the
presence of IL-2 (16 units/ml). Fluorescence was measured
every 24 h for 3 days to the monitor cell division rate on a
FACSCalibur (BD Biosciences) flow cytometer. Data obtained
were analyzed usingModFit LT 3.0.
Statistical Analysis—Student’s t test for the mean of two-
paired samples was used to determine the significance between
data means (**, p 0.05; ***, p 0.001).
RESULTS
PIX-Rho-GEF Leads to PYGM Activation—To test if PIX
could be a link between IL-2 receptor and Rac 1 leading to the
activation of PYGM, Kit 225 T cells were transfected with
pMT2-HA or pMT2-HA-PIX and stimulated or not with 500
units/ml of IL-2 for 10min, lysed, andPYGMactivitywas deter-
mined as described under “Experimental Procedures.” As
shown in Fig. 1A (first closed bar), IL-2 stimulated robust
PYGMactivity of empty vector-transfectedKit 225T cells. This
IL-2 stimulation of PYGM activity was already maximal and it
was not further increased inPIX-overexpressing cells (Fig. 1A,
second closed bar compared with first closed bar). However,
PIX overexpression in the absence of IL-2 resulted in a signif-
icant increase of the PYGM activity when compared with con-
trol cells (Fig. 1A, second empty bar compared with first empty
bar).Western blot showsPIX expression levels (Fig. 1A,upper
panel).
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Next, we aimed to determine whether other GEFs such as
Vav, Tiam-1, and/or STEF/Tiam-2 that preferentially activate
Rac 1 could also modulate the activity of the PYGM in our
cellular system. For that purpose, following the same procedure
described above, Kit 225 T cells were transfected with
pcDNA3-HA (empty vector), pEF-Vav, pcDNA3-HA-Tiam-1,
and pcDNA3-HA-STEF, and 24 h post-transfection PYGM
activity was determined in Kit 225 T cells unstimulated and
stimulated with IL-2 for 10 min. As expected, IL-2 significantly
increased PYGM activity compared with unstimulated cells
(Fig. 1B, first and second bars). This maximal increase in the
PYGMactivity induced by IL-2 also occurred in the presence of
Vav and STEF (Fig. 1B, fourth and eighth bars compared with
the second bar). However, in contrast to thePIXoutcome,Vav
or STEF overexpression per se did not modify PYGM activity
(Fig. 1B, third and seventh bars). In sharp contrast, Tiam-1
overexpression dramatically blocked PYGM activity (Fig. 1B,
sixth bar). Western blots show Vav, STEF, and Tiam-1 expres-
sion levels (Fig. 1B, upper panel).
Finally, to corroborate that PIX was specifically regulating
the glycogen phosphorylase activity in IL-2-stimulated T cells,
pix was knocked down in Kit 225 T cells. To this end, Kit
225 T cells were transfected with esiRNA human ARHGEF6
(PIX) or esiRNA targeting EGFP, as negative control. 24 h
post-transfection PYGM activity was determined in Kit 225
T cells unstimulated and stimulated with IL-2 for 10 min. As
shown in Fig. 1C, IL-2 stimulated robust PYGM activity in
egfp(esiRNA)-transfected Kit 225 T cells. pix knockdown
(pix(esiRNA)) cells stimulated by IL-2 for 10min did not show
any PYGM activity (Fig. 1C, second closed bar compared with
first closed bar). Furthermore, in the absence of IL-2 pix
knockdown, cells also displayed no PYGM activity, in contrast
to PIX overexpressing cells (Fig. 1, C, second empty bar com-
pared with A, second empty bar). Small aliquots of cell lysate
from each condition were stored, electrophoretically resolved
by SDS-PAGE, and followed byWestern blot. Immunoreactive
bands were visualized with specific antibodies as indicated. Fig.
1C, first and second panels show PIX expression levels after
esiRNA transfection and tubulin, respectively. The -tubulin
Western blot result shows that an equivalent amount of protein
was used in each of the conditions analyzed.
Rac 1/PYGM Pathway Activation Depends on the Integrity of
PIX Serine 225 and 488 Residues—To demonstrate that PIX
functions as a Rac-activating molecule in Kit 225 T cells, PIX
was knocked-down with pix(esiRNA), as we described above
and the endogenous active Rac 1wasmeasured by the pulldown
assay. As shown in Fig. 2A, in the absence of PIX (knock-
down), IL-2 was unable to stimulate Rac 1 activation (fourth
lane compared with second lane). PIX expression levels in the
presence of esiRNA control (egfp) or pix(esiRNA) were deter-
mined byWestern blot (Fig. 2A, upper panel). Rac 1 detected in
whole cell lysates shows that the total loaded proteins are equiv-
alent in all lanes (Fig. 2A, third panel).
Directed mutagenesis was used to investigate a putative role
of serine 225 and 488 residues in activation of the Rac 1/PYGM
pathway. To this end, the following single PIX mutants were
FIGURE1. IL-2 stimulatesglycogenphosphorylaseactivity inKit225Tcells throughPIXRho-GEF.Kit 225Tcells deprivedof IL-2 for 24hwere transfected
withplasmids coding for:A, pMT2-HA (emptyvector) andpMT2-HA-PIX;B, pcDNA3-HA (emptyvector), pEF-Vav1, pcDNA3-HA-Tiam-1, andpcDNA3-HA-STEF;
and C,pix(esiRNA) and egfp(esiRNA).As a control, 24 h post-transfection cells were stimulated () or not () with 500 units/ml of IL-2 for 10min and lysed. Cell
extracts fromunstimulatedor stimulated cellswereused tomeasureglycogenphosphorylase activity, as describedunder “Experimental Procedures.”Western
blot (W.B.) analysis of protein expression levels was carried out using specific antibodies, as indicated. Results show the mean of three independent experi-
ments S.D. and statistical analysis shows a significant difference (***, p 0.001).
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generated:PIXS225A,PIXS488A, and thePIX doublemutant,
PIXS225A/S488A. The effects of these PIX mutants on IL-2-
stimulated Rac 1 activation were examined in Kit 225 T cells
previously transfected with PIX wt, PIXS225A, PIX488A,
PIXS225A/S488A, or the empty vector (pMT2-HA) and stimu-
lated or not with 500 units/ml of IL-2 for 10 min. The active
form of Rac 1 present in whole cell lysates was pulled down
using the fusion protein GST-RBD of PAK 1 and visualized as
described under “Experimental Procedures.” As shown in Fig.
2B (first panel), IL-2 stimulated Rac 1 activation (lane 2) in
control transfected cells.PIXwt overexpression inducedmas-
sive Rac 1 activation, which was not further increased by IL-2
stimulation (Fig. 2B, upper panel, lanes 3 and 4). In contrast,
both PIX single and doublemutants dramatically blocked Rac
1 activation stimulated by IL-2 (Fig. 2B, upper panel, sixth,
eighth, and tenth lanes). Furthermore, overexpression of these
PIX mutants in unstimulated cells did not induce any Rac 1
activation as it was observed with the PIX wild type form (Fig.
2B, upper panel, fifth, seventh, and ninth lanes compared with
third lane).
Next, the effect of thesePIXmutants on PYGMactivity was
also examined. As shown in Fig. 2C, IL-2 stimulated PYGM
maximal activity of both empty vector and PIX wt transfected
Kit 225 T cells (Fig. 2C, second and fourth bars, respectively).
PIX overexpression without IL-2 stimulation also induced a
significant increase in PYGM activity in comparison to control
cells (Fig. 2C, third bar compared with first bar). In contrast,
PYGMactivitywas completely blocked by both the single serine
and double serine mutants with or without IL-2 stimulation
(Fig. 2C, five right bars).
nPKCs Regulate Rac 1/PYGM Pathway Activation—To
search for additional kinases also involved in IL-2 early signal-
ing leading to PYGM activation, the possible involvement of
PKA, PI3K, and/or PKCs was examined. To this end, Kit 225 T
cells deprived of IL-2 for 48 h were pretreated for 1 h with
vehicle, 10 M H-89 (a PKA inhibitor), 20 M LY294002 (a
specific inhibitor of PI3K), 100 nMGö6976 (an inhibitor of clas-
sic PKCs,mainly and), or 5MRottlerin (whichwas initially
described as a selective inhibitor of the novel PKC isoform 
(46)) and was subsequently described to inhibit also PKC (47,
48), followed by stimulation or not with 500 units/ml of IL-2 for
10 min. PYGM activity was determined as described above.
Inhibition of PKA, PI3K, or classic PKCs did not affect PYGM
activity stimulated by IL-2 (Fig. 3A, fourth, sixth, and eighth bars
compared with second bar); notwithstanding, Rottlerin effi-
ciently blocked PYGM activity stimulated by IL-2 (Fig. 3A,
tenth bar) in a concentration-dependent manner (Fig. 3B). 2.5
M Rottlerin was the minimal concentration leading to the
maximal blockage (Fig. 3B).
To verify a putative connection between nPKC and PYGM in
Kit 225 T cells, PMA, a natural DAG analog, was used to
directly activate PKC. Kit 225 T cells deprived of IL-2 for 48 h
were stimulated with 500 units/ml of IL-2 for 10 min or 1 M
PMA for 15 min. PMA was able to stimulate maximal PYGM
activity; a response equivalent to the one produced by IL-2 (Fig.
3C, second and third bars). Accordingly, IL-2- and PMA-stim-
ulated PYGM activity was blocked in Rottlerin (2.5 M, for 1 h)
pretreated cells (Fig. 3C, fifth and sixth bars). Next, the impact
of PKCs inhibition on Rac 1 activation stimulated by IL-2 was
examined. Results presented here confirmed that IL-2 stimula-
tion correlated with an increase of the Rac 1 active form (Fig.
3D, first panel, second lane). IL-2 stimulated Rac 1 activation
was unaffected when classical PKCs were inhibited by 100 nM
Gö6975 (Fig. 3D, first panel, fourth lane). However, 2.5MRot-
tlerin almost completely blocked IL-2-stimulated Rac 1 activa-
FIGURE2. IL-2-stimulatedRac1/PYGMpathwayactivation requires intact
serine residues 225 and 488 of PIX-Rho-GEF. Kit 225 T cells deprived of
IL-2 for 24 h were transfected with egfp(esiRNA) and pix(esiRNA), pMT2-HA
(empty vector), pMT2-HA-PIX wt, pMT2-HA-PIXS225A, pMT2-HA-PIXS488A,
and PIXS225A/S488A. 24 h post-transfection cells were stimulated () or not
() with 500 units/ml of IL-2 for 10 min and lysed. A and B, cell lysates were
used to measure Rac 1 activation by affinity precipitation assay. Precipitated
active Rac1 (Rac1-GTP), total Rac1, andPIX expression levels of thewild type
and the mutant forms were analyzed by Western blot using anti-Rac1 and
anti-HA antibodies, respectively. Results are representative of four indepen-
dent experiments. C, cell extracts from unstimulated and stimulated cells
were used to measure glycogen phosphorylase activity, as described under
“Experimental Procedures.”Western blot (W.B.) analysis of protein expression
levelswas carried out using specific anti-HA antibody. Results show themean
of three independent experimentsS.D. and statistical analysis shows a sig-
nificant difference (***, p 0.001).
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tion (Fig. 3D, first panel, sixth lane). Finally, to determine
whether PMA could stimulate Rac 1 activation, Kit 225 T cells
deprived of IL-2 for 48 h were stimulated with 500 units/ml of
IL-2 for 10 min or with 1 M PMA for 15 min. As shown in Fig.
3E, both or IL-2-stimulated Rac 1 activation (first panel, second
and third lanes) where completely blocked by 2.5 M Rottlerin
(Fig. 3E, first panel, fifth and sixth lanes).
To further characterize the involvement of nPKCs in signal-
ing pathways stimulated by IL-2 leading to Rac 1/PYGM acti-
vation, Kit 225 T cells were transiently transfected with
pcDNA3 (empty vector) or with cDNAs encoding the , , and
 constitutively active isoforms of PKCs for 24 h, and Rac 1
activationwas analyzed. As shown in Fig. 4A, transfection of the
constitutively active form of PKC activated Rac 1 to a level
comparable with those obtained by IL-2 stimulation. The
potent stimulating effect of PKC was specific given that nei-
ther activated PKC or PKChad any effect onRac 1 activation.
In agreement with this neither PKC nor PKC increased the
basal level of PYGM activity, whereas constitutively active
PKC induced PYGM activity to levels comparable with that
stimulated by IL-2 (Fig. 4B).
To confirm the involvement of PKC in the Rac 1/PYGM
pathway, Rac 1 andPYGMactivationwas determined inKit 225
T cells overexpressing PKC (wt), PKCA148E (constitutively
active formof PKC), and PKCK409R (dominant-negative form
of PKC) with or without IL-2 stimulation. First, immunoblot-
ting showed that all forms of PKCwere equally expressed (Fig.
4, C, third panel, and D, upper panel). As shown in Fig. 4C,
transfection of the PKC constitutively active form was found
to activate Rac 1 to levels comparable with those stimulated by
IL-2. In fact, IL-2 stimulation of cells overexpressing PKC (wt)
or PKCA148E did not increase Rac 1 activation any further (Fig.
4 C, fourth and sixth lanes compared with second). In contrast,
transfection with PKCK409R completely abolished Rac 1 acti-
vation either with or without IL-2 stimulation (Fig. 4C, seventh
and eighth lanes). Similar results were obtained when PYGM
activity was measured. PKCA148E overexpression alone was
enough to stimulate maximal PYGM activity; equivalent to
PYGM activity stimulated by IL-2 (Fig. 4D, fifth bar compared
with second, fourth, and sixth bars). Finally, PKCK409R overex-
pression completely blocked PYGM activity either with or
without IL-2 stimulation (Fig. 4D, seventh and eighth bars).
To confirm results obtained with PKC demonstrating that
this serine-threonine kinase functions as a Rac 1/PYGM-acti-
vating molecule in Kit 225 T cells, PKC was knocked down
with pkc (esiRNA), as described above. The endogenous Rac 1
active state was measured by the pulldown assay. As shown in
Fig. 4E, in the absence of PKC (knockdown) IL-2 stimulation
was unable to induce Rac 1 activation (fourth lane compared
with second lane). The PKC expression level in cells trans-
fected with esiRNA control (egfp) or pkc(esiRNA) was deter-
mined byWestern blot (Fig. 4E, upper panel). Rac 1 detected in
whole cell lysates shows that the loaded proteins were equiva-
lent in all lanes (Fig. 4E, third panel). When PYGM activity in
FIGURE 3. nPKCs regulate Rac 1/PYGM activation in IL-2-stimulated T cells. A–C, Kit 225 T cells were treated with inhibitors or vehicle (dimethyl sulfoxide)
for 1 h and subsequently unstimulated (empty bars) or stimulated (closed bars) with 500 units/ml of IL-2 for 10 min (A and B) or 1 M PMA for 15 min (C) as
indicated. Cells were lysed and extracts were used tomeasure glycogen phosphorylase activity. Results show themean of three independent experiments
S.D., and statistical analysis shows a significant difference (***,p 0.001).D and E, Kit 225 T cellswere treatedwith PKC inhibitors or vehicle (dimethyl sulfoxide)
for 1 h and stimulated or not with 500 units/ml of IL-2 for 10min (D) or 1M PMA for 15min (E) as indicated and lysed. Cell extracts were used tomeasure Rac1
activation by affinity precipitation assays. Precipitated active Rac 1 (Rac 1-GTP) and total Rac 1 from cell lysates were analyzed by Western blot (W.B.) using
anti-Rac 1 specific antibody. Results are representative of three independent experiments.
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PKC knockdown Kit 225 T cells stimulated with IL-2 was
examined, it was observed that in the absence of PKC IL-2 was
unable to stimulate PYGMactivation (Fig. 4F). Small aliquots of
whole cell lysate from each condition were stored, electropho-
rectically separated on SDS-PAGE, and followed by Western
blot. Immunoreactive bands were visualized with specific anti-
bodies as indicated. Fig. 4F (first and second panels) shows
PKC expression levels after esiRNA transfection and -tubu-
lin, respectively. -Tubulin blot analysis indicates that equiva-
lent amounts of protein were used in SDS-PAGE analysis.
PKC Controls PIX Phosphorylation in Vivo and in Vitro—
To test whether or not nPKCs could phosphorylatePIX serine
residues when Kit 225 T cells were stimulated by IL-2,
HA-PIX overexpressing cells were pretreated or not with 2.5
MRottlerin for 1 h, and stimulated or not with 500 units/ml of
IL-2 for 10 min. HA-PIX present in cell lysates was immuno-
precipitated using anti-HA antibody, as described under
“Experimental Procedures.” As shown in Fig. 5A (first left panel,
fourth lane), IL-2 stimulated PIX serine phosphorylation,
which was blocked by Rottlerin (Fig. 5A, first right panel, fourth
lane). Given that these experiments were performed in PIX
overexpressing cells, endogenous PIX phosphorylation was
also examined. Kit 225 T cells were transfected with pkc
(esiRNA) to knockdown PKC and cell lysates were immuno-
precipitated using anti-PIX antibody, as described under
“Experimental Procedures.” As shown in Fig. 5B (fourth lane 4
compared with second lane), in the absence of PKC expres-
sion, IL-2 was unable to induce PIX serine phosphorylation.
To determine the amount of immunoprecipitated PIX, mem-
branes that were used to examine the PIX serine phosphory-
lation were stripped and reblotted with anti-PIX antibody
(Fig. 5B, second panel). PKC expression levels in the presence
of esiRNA control (egfp) or pkc (esiRNA) present in whole cell
lysates were also examined by SDS-PAGE and followed by
Western blot. Immunoreactive bands were visualized using
anti-PKC antibody (Fig. 5B, third panel).Tubulin shows that
FIGURE 4. PKCmediates Rac-1 and PYGMactivation in Kit 225 T cells. Kit 225 T cells deprived of IL-2 for 24 hwere transfected (A and B) with empty vector
orwith constitutively activemutants of PKC, PKC, andPKC (C andD)with empty vector or cDNAs encodingPKC (wt), PKCA148E (constitutively active form),
and PKCK409R (dominant-negative form) and (E and F), with egfp(esiRNA) and pkc (esiRNA). 24 h post-transfection cells were stimulated or not with 500
units/ml of IL-2 for 10min and lysed.A,C, and E, cell extractswereused tomeasure Rac 1 activationby affinity precipitation assays. Precipitated active Rac 1 (Rac
1-GTP) and total Rac 1 fromcell lysateswere analyzedbyWesternblot (W.B.) using anti-Rac 1 specific antibody. Results are representative of three independent
experiments. The expression levels of PKCA25E, PKCA159E, and PKCA148E were visualized using anti-PKC antibody to detect PKCA25E, and anti-HA antibody
to detect both PKCA159E and PKCA148E, and endogenous PKC (E) was visualized using anti-PKC antibody. B, D, and F, cell lysates were used to examine
glycogen phosphorylase activity. Results show themean of three independent experiments S.D., and statistical analysis shows a significant difference (***,
p  0.001) in histograms B and D and (**, p  0.05) in histogram E. Immunoreactive bands in B and D corresponding to the expression levels of PKCA25E,
PKCA159E, and PKCA148E were visualized using anti-PKC antibody to detect PKCA25E, and anti-HA antibody to detect both PKCA159E and PKCA148E.
Endogenous PKC (E) and -tubulin (E) were visualized using anti-PKC and anti--tubulin antibodies
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total protein was equivalent in all assay conditions (Fig. 5B,
fourth panel). These results suggest thatPIX serine phosphor-
ylation stimulated by IL-2 requires PKC protein expression.
As shown in Fig. 2, PIX serine residues 225 and 488 are
required for Rac 1 and PYGM activation in IL-2-stimulated Kit
225T cells. Therefore, to determinewhether or not PKC could
phosphorylate the PIX region comprising both serines, an in
vitro kinase assay was performed using a GST-PIX204–532
fusion protein as an exogenous substrate for PKC. The GST
moiety was fused to the PIX region spanning from 204 to 532
residues, as described under “Experimental Procedures.”
Briefly, to carry out the in vitro kinase assay PKCA25E,
PKCA159E, and PKCA148E were immunoprecipitated from
cell lysates derived from stimulated or unstimulated Kit 225 T
cells and immunocomplexes were incubated with ATP and
GST-PIX204–532. Subsequently, proteins were resolved by
SDS-PAGE followed by Western blot and GST-PIX204–532
serine phosphorylation was visualized using an anti-phospho-
serine antibody. As illustrated in Fig. 5C, PKCA148E induced
robust GST-PIX204–532 serine phosphorylation and it was not
modified by IL-2 stimulation (fifth and sixth lanes). However,
serine phosphorylation was not detectable either in the pres-
ence of PKCA25E or PKCA159E (Fig. 5C, from first to fourth
lanes).
To confirm PKC involvement in the PIX204–532 region
serine phosphorylation, Kit 225 T cells were transiently trans-
fected with pcDNA3 (empty vector) or with cDNAs encoding
PKC (wt), PKCA148E (constitutively active form), and
PKCK409R (dominant-negative form). Equal expression levels
of these PKC forms in Kit 225 T cells were confirmed by
immunoblotting (Fig. 5D). As shown in Fig. 5D (second lane),
IL-2 stimulatesGST-PIX204–532 serine phosphorylation inKit
225 T cells overexpressing PKC (wt). When the effect of
PKCA148E overexpression on GST-PIX204–532 phosphoryla-
tion was examined, a stronger level of exogenous substrate
phosphorylation was observed than that found in cells overex-
pressing PKC (wt) and stimulated by IL-2 (Fig. 5D, third lane
compared with second lane). IL-2 stimulation of PKCA148E
overexpressing cells did not increase the phophorylation level
further than that of unstimulated PKCA148E overexpressing
cells (Fig. 5D, third and fourth lanes). In contrast, transfection
with PKCK409R (PKC, dominant-negative) completely
blocked GST-PIX204–532 phosphorylation independently of
IL-2 stimulation (Fig. 5D, fifth and sixth lanes).
PKC and PIX Are Needed for IL-2-induced Chemotaxis
and Proliferation of Kit 225 T Cells—To investigate the role of
PKC and PIX in IL-2-stimulated Kit 225 T cell migration,
cells were transfected with egfp (as control), pkc, or pix
(esiRNAs) and their effects on the IL-2-induced T cell che-
motaxis through polyethylene terephthalate membranes were
examined. As shown in Fig. 6A, IL-2 stimulated robust migra-
tion of Kit 225 T cells (first solid bar). On the other hand, lack of
either PKC or PIX expression abolished Kit 225 T cells
migration stimulated by IL-2 (Fig. 6A, second and third solid
bars). At the end of the experiment, cells in the upper and lower
chambers from each transfected condition were mixed. Cells
were lysed and whole cell lysates were separated by SDS-PAGE
followed by Western blot. The expression levels of PIX and
PKC were visualized using specific antibodies as indicated in
Fig. 6A (first and second panels). -Tubulin Western blot anal-
ysis shows that equal amounts of protein were used (Fig. 6A,
third panel).
FIGURE 5.PIX serine phosphorylation depends on PKC in intact Kit 225 T cells. Kit 225 T cells deprived of IL-2 for 24 h were transfected with (A), empty
vector (pMT2-HA) or pMT2-HA-PIX (wt), and (B) with egfp(esiRNA) and pkc(esiRNA). A, 24 h post-transfection an aliquot of cells were pretreated with 2.5 M
Rottlerin or vehicle (dimethyl sulfoxide) for 1 h. Subsequently, cells were stimulated or not with 500 units/ml of IL-2 for 10 min and lysed. B, 24 h post-
transfection cells were stimulated or not with 500 units/ml of IL-2 for 10min and lysed. Cell lysates were subjected to immunoprecipitationwith anti-HA (A) or
anti-PIX (B) antibodies and immunoreactive bands were visualized using anti-phosphoserine, anti-HA, anti-PIX, anti-PKC, and anti--tubulin antibodies.
Results are representative of three independent experiments. C, Kit 225 T cells deprived of IL-2 for 24 h were transfected with empty vector or with the
constitutively active mutants of PKC, PKC, and PKC. D, Kit 225 T cells deprived of IL-2 for 24 h were transfected with cDNAs encoding PKC (wt), PKCA148E
(constitutively active form), and PKCK409R (dominant-negative form). 24 h post-transfection cells were stimulated or not with 500 units/ml of IL-2 for 10 min
and lysed. Cell extracts were immunoprecipitated with anti-PKC and anti-HA antibodies (C) and anti-HA antibody (D). Immunocomplex activities were
analyzedby an in vitro kinase assay followedby SDS-PAGE andWestern blot. Immunoreactive bandswere visualized using anti-phosphoserine (pS) antibodies.
In addition, to determine the amount of GST-PIX204–532, aliquots of lysates were analyzed by Western blot (W.B.) using anti-GST antibody. The expression
levels of PKCA25E, PKCA159E, PKC (wt), PKCA148E, and PKCK409R were visualized using anti-PKC to detect PKCA25E and anti-HA antibody to detect
PKCA159E and PKC (wild type and mutants). Results are representative of three independent experiments.
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To evaluate the role of PKC and PIX in IL-2-stimulated
cell proliferation, esiRNAs for egfp, pkc, and pix were used.
Cell proliferation was analyzed after flow cytometry by moni-
toring the decrease in fluorescence of dye PKH6 incorporated
in cell membrane, which is diluted approximately 2-fold with
each cell division. PKH26-labeled cells were treated with 16
units/ml of IL-2 every 24 h for 3 days. In control cells (egfp
(esiRNA) transfected cells) cultured for 3 days, IL-2 stimulation
resulted in approximately a 2-fold increase in cell number (Fig.
6B, closed circles) compared with IL-2-unstimulated cells (Fig.
6B, open circles). Remarkably, IL-2-stimulated cell proliferation
was significantly reduced with either pkc (esiRNA) (Fig. 6B,
closed triangles) or with pix(esiRNA) (Fig. 6B, closed dia-
monds) knockdown. At the beginning of the experiment, 3 
105 cells from each transfected condition were taken and lysed.
Total protein in lysates was separated by SDS-PAGE followed
by Western blot. The expression level of PIX and PKC was
visualized using specific antibodies as indicated in Fig. 6B (first
and second panels). -Tubulin Western blot analysis indicates
that equal amounts of protein were used in the analysis (Fig. 6B,
third panel).
DISCUSSION
Small GTPases of the Rho family actively participate in the
immune response after antigenic stimulation, allowing for
appropriate actin cytoskeleton reorganization and regulation of
transcription factors activity (53). Cooperation between tran-
scription factors such as NFAT, NF-	B, and JNK is key to guar-
antee an adequate T cell clonal proliferation; in part by regulat-
ing transcription of IL-2 and the  chain of the IL-2R (49).
Recently, we reported that upon IL-2R activation in Kit 225 T
cells, the Rac 1 GTPase active form binds to and activates the
metabolic enzyme PYGM, leading to cell proliferation (13). In
the present study, we show that the IL-2/IL2-R engagement
signals to theRac 1/PYGMpathway throughPKC and theGEF
PIX. More importantly, we identify PIX as a Rac 1-specific
GEF in IL-2-stimulated T cells and provide novel evidence
demonstrating that PIX requires serine phosphorylation by
PKC to control the Rac 1/PYGM pathway, and thereby regu-
late T cell migration and proliferation.
Signals emanating from membrane receptors such as TCR,
BCR, and IL-2R leading not only to the activation of protein-
tyrosine kinases, but also of serine/threonine kinases, can pos-
itively regulate downstream effectormolecules, including small
GTPases of the Ras superfamily (18, 50). However, little is
known about which Rho-GEF activates Rho GTPases after IL-2
receptor activation. Kit 225 T cells express IL-2R constitutively
and depend exclusively on IL-2 for cellular proliferation (41).
This feature represents an important advantage for IL-2-stim-
ulated signaling studies and this cellular systemhas emphasized
the importance of RhoA (51) and Rac 1 (12, 13) in T cell biology
regulated by IL-2.
Given that tyrosine phosphorylation of cellular proteins is
one of themost important and characteristic events in early cell
signaling stimulated by IL-2, Osinalde et al. (35) used high res-
olution mass spectrometry, combined with phosphotyrosine
immunoprecipitation and stable isotope labeling by amino
acids in cell culture (SILAC) to identify 172 tyrosine-phosphor-
ylated target proteins; among which is PIX-RhoGEF. This
result prompted us to examine the potential participation of
PIX in PYGM activation. Overexpression experiments with
PIX demonstrated a significant increase in PYGM activity in
the absence of any stimuli. PIX overexpression promotes its
own spontaneous dimerization in the absence of any stimuli,
and in this configuration PIX activates Rac 1 (52). Further-
more, in the presence of IL-2, PIX-transfected cells reached a
maximum level of PYGM activity. However, these results do
not exclude the possibility that other GEFs capable of undergo-
ing tyrosine phosphorylation may be involved in this signaling
FIGURE 6. PKC/PIX pathway mediates IL-2-stimulated Kit 225 che-
motaxis and proliferation. A, esiRNA (egfp, pkc, pix) transfected Kit 225 T
cells migration was studied in a Transwell assay. Data representing the per-
centage of migrating cells are expressed as the mean of three independent
experiments S.D. and statistical analysis shows a significant difference (***,
p 0.001). At the endof the assay, cellswere recovered, lysed, and cell lysates
were analyzedbyWesternblot (W.B.) using specific antibodies as indicated.B,
esiRNA (egfp, pkc, pix)-transfected Kit 225 T cells were stained with PKH26.
Fluorescencewas analyzedbefore IL-2 stimulation (IL-2 (0 h) andafter every
24-h incubationwith IL-2 (IL-2) for 3 consecutive days. Results represent the
mean of three independent experiments  S.D. and the statistical analysis
showed a significant difference (**, p 0.05 and ***, p 0.001). 3 105 Kit
225 T cells were taken for each transfection condition, lysed, and cell lysates
were analyzed by Western blot using specific antibodies as indicated.
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pathway stimulated by IL-2. In fact, following this hypothesis
we proposed that Rac 1might also requireVavRho-GEF to bind
to and activate PYGM. Vav is the main GEF for Rac 1 in the
hematopoietic system and its GEF function targeting the Rho
family of GTPases is modulated by tyrosine phosphorylation at
residue 174 (26, 27). Evans et al. (53) also reported than in
peripheral blood lymphocytes, Vav is tyrosine phosphorylated
after IL-2 stimulation. However, in Vav overexpressing Kit 225
T cells there is no increase of PYGM activity. In our view, this
was quite an expected result. This is because specifically Vav
Tyr174 must be phosphorylated (26, 27) to release its DH
domain from its inhibitory configuration and thus gain access
to and activate Rac 1 (27). When the effect of IL-2 on Tyr174
phosphorylation was examined, it was observed that this cyto-
kine was not able to stimulate Tyr174 phosphorylation (data not
shown). These results do not contradict the observations
reported by Evans et al. (53), given that this group described
general tyrosine phosphorylation of Vav occurringmostly in its
SH2 domain and located at Vav carboxyl-terminal region;
whereas, Tyr174 is located between Vav CH andDH domains at
the amino-terminal region (26, 27).
From the start our results showed that PIX, and not Vav,
mediated PYGM activation in IL-2-stimulated Kit 225 T cells.
Although, additional GEFs from the Dbl family of exchange
factors such as Tiam-1 and STEF are capable of activating Rac 1
(28, 54), these GEFs have not been reported as being activated
by tyrosine phosphorylation, but rather Tiam-1 was reported
being activated by threonine phosphorylation (30), whereas
STEF was reported being activated by serine/threonine phos-
phorylation (31). Even so, their effects on PYGM activity were
evaluated. When these GEFs were individually overexpressed
inKit 225T cells, it was observed that neither of them increased
PYGM activity. Moreover, overexpression of Tiam-1 seems to
have a dominant-negative effect on PYGM activity. Further-
more, when we examined the effects of PIX knockdown with
pix(esiRNA) on either PYGM activity or Rac 1 activation, it
was observed that the absence of the PIX-Rho-GEF expres-
sion was enough to block activation of the Rac 1/PYGM path-
way. Collectively, these results strongly suggest that PIX is the
only GEF responsible for activation of the Rac 1/PYGM path-
way in Kit 225 T cells stimulated by IL-2.
Even if the PIX predicted phosphorylation sites were the
serines phosphorylated at residues 225 and 488 rather tyrosine
residues (35), this prediction does not contradict experimental
evidence obtained from SILAC-based quantitative phospho-
proteomics data (35), because a protein enriched by immuno-
precipitation with antiphosphotyrosine antibody upon IL-2
stimulation does not necessarily mean that it has been tyrosine
phosphorylated in response to that cytokine. Any non-tyro-
sine-phosphorylated proteins may also be enriched if it is
bound to a tyrosine-phosphorylated protein. The prediction
that PIX serine residues 225 and 488 may be susceptible to
being phosphorylated in Kit 225 T cells (35) is consistent with
the phosphoproteomic data obtained fromES and iPS cells (36),
KG1 AML cells (37), and colorectal cancer cells (38).
From a functional point of view, phosphorylation/dephos-
phorylation cycles aremajor early events in intracellular signal-
ing cascades. Therefore, the importance of these two PIX-
RhoGEF residues (Ser225 and Ser488) on Rac 1 and the
subsequent PYGM activation was examined. The results
obtained are compelling; both residues are essential to control
Rac 1 activation and PYGM enzymatic activity. In addition, by
pharmacological and genetic (either by PKC loss or gain of
function) approaches wewere able to find out that PKCwas in
control ofPIXphosphorylation and therefore activation of the
Rac 1/PYGM pathway in Kit 225 T cells. The involvement of
PKC in this cellular model is a novel finding although not a
surprising one; given that its expression is restricted to certain
tissues and cell types, including T cells (55). Since the relevance
of this serine/threonine kinase in regulating the dynamics of the
immunological synapse was described (56–58), many addi-
tional functions have been discovered, such as the control of
NF-	B, AP-1, and NFAT transcription factors activation,
which regulate the expression of proinflammatory cytokines
and anti-proapoptotic molecules Bcl-XL (59). Moreover, the
adhesive capacities of T lymphocytes (60) is the mechanism
through which stable adhesion between T cells and antigen
presenting cells is achieved (55, 61, 62). More recently, a new
role for PKC in T cell physiology was described; i.e. PKC
participation in the CCR7 downstream signaling driving T cell
migration (63). Therefore, the present findings are in agree-
ment with those reported by Cannon et al. (63) that not only
stimulated IL-2 T cell proliferation but also T cell migration is
regulated by the PKC/PIX axis upstream of Rac 1/PYGM.
In conclusion, our findings reveal the mechanism through
which IL-2 stimulates Rac 1 activation in Kit 225 T cells. We
identified PIX as the GEF that specifically activates Rac 1 and
consequently regulates PYGM activation, as well as the molec-
ular mechanism of PIX activation of the Rac1/PYGM path-
way. Regulation of this novel metabolic pathway requires that
PKC phosphorylates PIX serine residues participating in the
control of T cell migration and/or proliferation. Mechanisti-
cally, the specific molecular players connecting the activated
IL-2R and the PKC/PIX/Rac 1/PYGM pathway, and also
PYGM downstream signaling targets are still unknown. Future
studies will allow us to characterize the signaling molecules
upstream of PKC and effector molecules that participate in
this signal transduction pathway.
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